Health Care & Life Sciences » Pharmaceuticals | Tianjin Lisheng Pharmaceutical Co. Ltd.

Tianjin Lisheng Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,030
764
766
830
1,002
1,468
Cost of Goods Sold (COGS) incl. D&A
376
353
354
377
400
450
Gross Income
654
411
412
453
602
1,018
SG&A Expense
344
318
280
340
506
846
EBIT
303
85
130
112
94
168
Unusual Expense
-
-
11
18
-
8
Non Operating Income/Expense
-
22
5
11
10
37
Interest Expense
-
2
2
3
4
3
Pretax Income
352
108
137
132
132
216
Income Tax
55
19
21
18
14
29
Equity in Affiliates
1
4
1
1
2
2
Consolidated Net Income
298
93
114
116
117
185
Net Income
298
93
114
116
117
185
Net Income After Extraordinaries
298
93
114
116
117
185
Net Income Available to Common
298
93
114
116
117
185
EPS (Basic)
1.63
0.51
0.63
0.63
0.64
1.01
Basic Shares Outstanding
182
182
182
182
182
182
EPS (Diluted)
1.63
0.51
0.63
0.63
0.64
1.01
Diluted Shares Outstanding
182
182
182
182
182
182
EBITDA
327
111
155
161
150
222
Other Operating Expense
6
8
2
1
2
5
Non-Operating Interest Income
21
18
8
41
32
21
Minority Interest Expense
-
-
-
-
-
-

About Tianjin Lisheng Pharmaceutical Co.

View Profile
Address
No. 16 Saida North 1st Street
Tianjin Tianjin 300385
China
Employees -
Website http://www.lishengpharma.com
Updated 07/08/2019
Tianjin Lisheng Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of drugs. It specializes in western medicine, hard capsules, granules, water injection. injection, pills, pharmaceutical raw materials and other related products.